Amedisys (AMED) Buy Rating Reaffirmed by SunTrust Robinson; With $80.0000 Target; Granahan Investment Management Has Lifted Douglas Dynamics (PLOW) Stake

April 17, 2018 - By Marie Mckinney

Amedisys, Inc. (NASDAQ:AMED) Logo

Granahan Investment Management Inc increased Douglas Dynamics (PLOW) stake by 2.95% reported in 2017Q4 SEC filing. Granahan Investment Management Inc acquired 8,730 shares as Douglas Dynamics (PLOW)’s stock rose 10.82%. The Granahan Investment Management Inc holds 304,699 shares with $11.52M value, up from 295,969 last quarter. Douglas Dynamics now has $1.02B valuation. The stock increased 0.34% or $0.15 during the last trading session, reaching $44.75. About 20,517 shares traded. Douglas Dynamics, Inc. (NYSE:PLOW) has risen 41.20% since April 17, 2017 and is uptrending. It has outperformed by 29.65% the S&P500.

Expert analysts at SunTrust Robinson have $80.0000 price target on Amedisys (NASDAQ:AMED). SunTrust Robinson’s price target indicates a potential upside of 19.74% from the company’s previous stock close. The rating was revealed to clients and investors in an analyst report on 17 April.

Analysts await Amedisys, Inc. (NASDAQ:AMED) to report earnings on May, 1. They expect $0.66 EPS, up 40.43% or $0.19 from last year’s $0.47 per share. AMED’s profit will be $22.43M for 25.31 P/E if the $0.66 EPS becomes a reality. After $0.56 actual EPS reported by Amedisys, Inc. for the previous quarter, Wall Street now forecasts 17.86% EPS growth.

Investors sentiment increased to 1.77 in Q4 2017. Its up 0.06, from 1.71 in 2017Q3. It improved, as 12 investors sold Amedisys, Inc. shares while 44 reduced holdings. 39 funds opened positions while 60 raised stakes. 31.82 million shares or 0.22% more from 31.75 million shares in 2017Q3 were reported. Los Angeles Cap Management & Equity Rech stated it has 75,053 shares or 0.02% of all its holdings. Us Bancorp De stated it has 1,484 shares or 0% of all its holdings. Ls Advisors Ltd Liability holds 0.01% or 3,564 shares in its portfolio. Paloma Mngmt owns 0% invested in Amedisys, Inc. (NASDAQ:AMED) for 5,884 shares. State Board Of Administration Of Florida Retirement has 0% invested in Amedisys, Inc. (NASDAQ:AMED). Art Ltd Llc has invested 0.01% in Amedisys, Inc. (NASDAQ:AMED). State Street owns 788,913 shares. Tiaa Cref Invest Mngmt Lc has invested 0% in Amedisys, Inc. (NASDAQ:AMED). California State Teachers Retirement System invested in 44,924 shares. Principal Financial Group invested 0.01% in Amedisys, Inc. (NASDAQ:AMED). Macquarie Gp Ltd stated it has 0% in Amedisys, Inc. (NASDAQ:AMED). Captrust Fincl Advsrs reported 0% in Amedisys, Inc. (NASDAQ:AMED). Comerica Comml Bank invested in 0.01% or 29,234 shares. 2,453 are owned by Riverhead Cap Ltd Limited Liability Company. Bowling Port Mngmt Llc owns 40,711 shares for 0.29% of their portfolio.

The stock increased 0.74% or $0.49 during the last trading session, reaching $66.81. About 126,553 shares traded. Amedisys, Inc. (NASDAQ:AMED) has risen 18.43% since April 17, 2017 and is uptrending. It has outperformed by 6.88% the S&P500.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. The company has market cap of $2.27 billion. It operates through three divisions: Home Health, Hospice, and Personal Care. It has a 75.92 P/E ratio. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

Among 15 analysts covering Amedisys Inc. (NASDAQ:AMED), 8 have Buy rating, 0 Sell and 7 Hold. Therefore 53% are positive. Amedisys Inc. has $70.0 highest and $39 lowest target. $60.36’s average target is -9.65% below currents $66.81 stock price. Amedisys Inc. had 41 analyst reports since September 1, 2015 according to SRatingsIntel. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Hold” rating by RBC Capital Markets on Monday, June 5. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Buy” rating by SunTrust on Monday, October 9. The stock of Amedisys, Inc. (NASDAQ:AMED) has “Outperform” rating given on Monday, March 19 by RBC Capital Markets. On Thursday, March 10 the stock rating was maintained by Oppenheimer with “Outperform”. As per Friday, May 6, the company rating was maintained by RBC Capital Markets. The stock has “Outperform” rating by Oppenheimer on Monday, February 8. The rating was maintained by Mizuho with “Neutral” on Wednesday, March 1. Craig Hallum maintained Amedisys, Inc. (NASDAQ:AMED) on Thursday, November 9 with “Buy” rating. On Friday, June 17 the stock rating was initiated by Stephens with “Equal-Weight”. Jefferies maintained Amedisys, Inc. (NASDAQ:AMED) on Tuesday, September 5 with “Buy” rating.

Among 3 analysts covering Douglas Dynamics (NYSE:PLOW), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Douglas Dynamics had 8 analyst reports since August 4, 2015 according to SRatingsIntel. Seaport Global downgraded the stock to “Neutral” rating in Wednesday, July 6 report. Sidoti initiated the shares of PLOW in report on Monday, February 27 with “Buy” rating. The firm has “Market Perform” rating by Oppenheimer given on Tuesday, August 4. The stock of Douglas Dynamics, Inc. (NYSE:PLOW) earned “Buy” rating by Seaport Global on Tuesday, May 24. The rating was maintained by Craig Hallum on Wednesday, February 28 with “Buy”. The rating was maintained by Seaport Global with “Hold” on Tuesday, January 16. On Wednesday, April 20 the stock rating was initiated by Seaport Global with “Neutral”.

Since December 11, 2017, it had 0 buys, and 9 insider sales for $4.88 million activity. On Tuesday, March 6 the insider Janik James L sold $786,435. Sievert Jonathon P. sold $62,532 worth of stock. 8,494 Douglas Dynamics, Inc. (NYSE:PLOW) shares with value of $369,366 were sold by McCormick Robert L. Another trade for 818 shares valued at $35,571 was sold by Young Robert J. DEJANA ANDREW also sold $32,223 worth of Douglas Dynamics, Inc. (NYSE:PLOW) on Tuesday, March 6. $183,030 worth of Douglas Dynamics, Inc. (NYSE:PLOW) was sold by Hagelin Keith.

Investors sentiment decreased to 1 in 2017 Q4. Its down 0.20, from 1.2 in 2017Q3. It is negative, as 11 investors sold PLOW shares while 43 reduced holdings. 17 funds opened positions while 37 raised stakes. 19.83 million shares or 0.40% more from 19.75 million shares in 2017Q3 were reported. Cadence Cap Mgmt Ltd Limited Liability Company holds 40,833 shares. First Merchants Corporation accumulated 7,750 shares. Legal & General Group Public Limited Co owns 5,451 shares. Eagle Asset Mgmt accumulated 0.01% or 65,355 shares. Invesco accumulated 54,448 shares. Df Dent Co reported 70,369 shares. Meeder Asset owns 116 shares or 0% of their US portfolio. North Star Management Corp holds 89,988 shares or 0.41% of its portfolio. Parallax Volatility Advisers LP has 0% invested in Douglas Dynamics, Inc. (NYSE:PLOW). John G Ullman Associate holds 0.04% or 5,900 shares. Tower Research Capital Ltd Liability (Trc) holds 0.02% or 3,148 shares in its portfolio. Whittier Trust reported 2,450 shares or 0% of all its holdings. Raymond James And Associates owns 9,764 shares for 0% of their portfolio. Wells Fargo And Communications Mn accumulated 1.37M shares or 0.01% of the stock. Teton Advisors Inc holds 0.03% of its portfolio in Douglas Dynamics, Inc. (NYSE:PLOW) for 10,000 shares.

Granahan Investment Management Inc decreased Ironwood Pharmaceuticals (NASDAQ:IRWD) stake by 44,800 shares to 391,200 valued at $5.86 million in 2017Q4. It also reduced Zagg Inc (NASDAQ:ZAGG) stake by 33,088 shares and now owns 127,974 shares. Zendesk (NYSE:ZEN) was reduced too.

Amedisys, Inc. (NASDAQ:AMED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: